Logo image of VIV.PA

VIVENDI SE (VIV.PA) Stock Fundamental Analysis

EPA:VIV - Euronext Paris - Matif - FR0000127771 - Common Stock - Currency: EUR

2.847  -0.05 (-1.79%)

Fundamental Rating

2

VIV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 47 industry peers in the Entertainment industry. The financial health of VIV is average, but there are quite some concerns on its profitability. VIV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year VIV has reported negative net income.
In the past year VIV had a positive cash flow from operations.
In multiple years VIV reported negative net income over the last 5 years.
VIV had a positive operating cash flow in each of the past 5 years.
VIV.PA Yearly Net Income VS EBIT VS OCF VS FCFVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of -75.72%, VIV is doing worse than 91.49% of the companies in the same industry.
Looking at the Return On Equity, with a value of -130.75%, VIV is doing worse than 78.72% of the companies in the same industry.
Industry RankSector Rank
ROA -75.72%
ROE -130.75%
ROIC N/A
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
VIV.PA Yearly ROA, ROE, ROICVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

Looking at the Gross Margin, with a value of 28.96%, VIV is doing worse than 82.98% of the companies in the same industry.
In the last couple of years the Gross Margin of VIV has declined.
The Profit Margin and Operating Margin are not available for VIV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
VIV.PA Yearly Profit, Operating, Gross MarginsVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

4

2. Health

2.1 Basic Checks

VIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
VIV has less shares outstanding than it did 1 year ago.
VIV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, VIV has a worse debt to assets ratio.
VIV.PA Yearly Shares OutstandingVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIV.PA Yearly Total Debt VS Total AssetsVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

VIV has an Altman-Z score of 0.99. This is a bad value and indicates that VIV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.99, VIV is in line with its industry, outperforming 46.81% of the companies in the same industry.
VIV has a debt to FCF ratio of 1.46. This is a very positive value and a sign of high solvency as it would only need 1.46 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.46, VIV is in the better half of the industry, outperforming 74.47% of the companies in the same industry.
VIV has a Debt/Equity ratio of 0.54. This is a neutral value indicating VIV is somewhat dependend on debt financing.
VIV's Debt to Equity ratio of 0.54 is in line compared to the rest of the industry. VIV outperforms 46.81% of its industry peers.
Although VIV does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.46
Altman-Z 0.99
ROIC/WACCN/A
WACC5.91%
VIV.PA Yearly LT Debt VS Equity VS FCFVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

VIV has a Current Ratio of 0.24. This is a bad value and indicates that VIV is not financially healthy enough and could expect problems in meeting its short term obligations.
VIV has a Current ratio of 0.24. This is amonst the worse of the industry: VIV underperforms 95.74% of its industry peers.
A Quick Ratio of 0.24 indicates that VIV may have some problems paying its short term obligations.
VIV has a Quick ratio of 0.24. This is amonst the worse of the industry: VIV underperforms 95.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
VIV.PA Yearly Current Assets VS Current LiabilitesVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

1

3. Growth

3.1 Past

The earnings per share for VIV have decreased strongly by -1628.21% in the last year.
Looking at the last year, VIV shows a decrease in Revenue. The Revenue has decreased by -4.81% in the last year.
VIV shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -54.89% yearly.
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2857.24%
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-100%

3.2 Future

VIV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 143.58% yearly.
The Revenue is expected to decrease by -66.44% on average over the next years. This is quite bad
EPS Next Y528.3%
EPS Next 2Y194.68%
EPS Next 3Y143.58%
EPS Next 5YN/A
Revenue Next Year-96.41%
Revenue Next 2Y-80.81%
Revenue Next 3Y-66.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIV.PA Yearly Revenue VS EstimatesVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
VIV.PA Yearly EPS VS EstimatesVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

VIV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 37.39, which means the current valuation is very expensive for VIV.
The rest of the industry has a similar Price/Forward Earnings ratio as VIV.
VIV's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.19.
Industry RankSector Rank
PE N/A
Fwd PE 37.39
VIV.PA Price Earnings VS Forward Price EarningsVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

VIV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VIV is cheaper than 93.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.6
EV/EBITDA N/A
VIV.PA Per share dataVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VIV's earnings are expected to grow with 143.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y194.68%
EPS Next 3Y143.58%

2

5. Dividend

5.1 Amount

VIV has a Yearly Dividend Yield of 1.39%.
VIV's Dividend Yield is rather good when compared to the industry average which is at 1.84. VIV pays more dividend than 82.98% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, VIV's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

The dividend of VIV decreases each year by -13.55%.
Dividend Growth(5Y)-13.55%
Div Incr Years0
Div Non Decr Years2
VIV.PA Yearly Dividends per shareVIV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

VIV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.23%
EPS Next 2Y194.68%
EPS Next 3Y143.58%
VIV.PA Yearly Income VS Free CF VS DividendVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

VIVENDI SE

EPA:VIV (7/14/2025, 5:29:55 PM)

2.847

-0.05 (-1.79%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)04-28 2025-04-28
Earnings (Next)07-23 2025-07-23
Inst Owners25.97%
Inst Owner ChangeN/A
Ins Owners30.04%
Ins Owner ChangeN/A
Market Cap2.93B
Analysts70
Price Target3.08 (8.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly Dividend0.25
Dividend Growth(5Y)-13.55%
DP-4.23%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-98.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.39
P/S 9.87
P/FCF 1.6
P/OCF 1.59
P/B 0.64
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)-5.96
EYN/A
EPS(NY)0.08
Fwd EY2.67%
FCF(TTM)1.78
FCFY62.65%
OCF(TTM)1.79
OCFY62.75%
SpS0.29
BVpS4.46
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.72%
ROE -130.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.96%
FCFM 618.52%
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z 0.99
F-Score4
WACC5.91%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)44.94%
Cap/Sales(5y)29.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2857.24%
EPS Next Y528.3%
EPS Next 2Y194.68%
EPS Next 3Y143.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-100%
Revenue Next Year-96.41%
Revenue Next 2Y-80.81%
Revenue Next 3Y-66.44%
Revenue Next 5YN/A
EBIT growth 1Y-58.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.6%
EBIT Next 3Y31.38%
EBIT Next 5YN/A
FCF growth 1Y236.45%
FCF growth 3Y16%
FCF growth 5Y16.53%
OCF growth 1Y93.48%
OCF growth 3Y3.97%
OCF growth 5Y7.73%